Product NDC: | 63304-445 |
Proprietary Name: | Omeprazole Delayed-Release |
Non Proprietary Name: | Omeprazole |
Active Ingredient(s): | 40 mg/1 & nbsp; Omeprazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-445 |
Labeler Name: | Ranbaxy Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019810 |
Marketing Category: | NDA |
Start Marketing Date: | 20080725 |
Package NDC: | 63304-445-30 |
Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (63304-445-30) |
NDC Code | 63304-445-30 |
Proprietary Name | Omeprazole Delayed-Release |
Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (63304-445-30) |
Product NDC | 63304-445 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Omeprazole |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080725 |
Marketing Category Name | NDA |
Labeler Name | Ranbaxy Laboratories Inc. |
Substance Name | OMEPRAZOLE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |